These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
265 related items for PubMed ID: 30394321
1. Downregulation of Dopamine D1-like Receptor Pathways of GABAergic Interneurons in the Anterior Cingulate Cortex of Spontaneously Hypertensive Rats. Satoh H, Suzuki H, Saitow F. Neuroscience; 2018 Dec 01; 394():267-285. PubMed ID: 30394321 [Abstract] [Full Text] [Related]
6. Hypodopaminergic and hypernoradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder--the spontaneously hypertensive rat. Russell VA. Behav Brain Res; 2002 Mar 10; 130(1-2):191-6. PubMed ID: 11864734 [Abstract] [Full Text] [Related]
7. Dopamine increases inhibition in the monkey dorsolateral prefrontal cortex through cell type-specific modulation of interneurons. Kröner S, Krimer LS, Lewis DA, Barrionuevo G. Cereb Cortex; 2007 May 10; 17(5):1020-32. PubMed ID: 16772311 [Abstract] [Full Text] [Related]
10. Differential distribution, affinity and plasticity of dopamine D-1 and D-2 receptors in the target sites of the mesolimbic system in an animal model of ADHD. Carey MP, Diewald LM, Esposito FJ, Pellicano MP, Gironi Carnevale UA, Sergeant JA, Papa M, Sadile AG. Behav Brain Res; 1998 Jul 10; 94(1):173-85. PubMed ID: 9708848 [Abstract] [Full Text] [Related]
11. Bidirectional dopamine modulation of GABAergic inhibition in prefrontal cortical pyramidal neurons. Seamans JK, Gorelova N, Durstewitz D, Yang CR. J Neurosci; 2001 May 15; 21(10):3628-38. PubMed ID: 11331392 [Abstract] [Full Text] [Related]
16. Dopamine inhibition of evoked IPSCs in rat prefrontal cortex. Gonzalez-Islas C, Hablitz JJ. J Neurophysiol; 2001 Dec 15; 86(6):2911-8. PubMed ID: 11731547 [Abstract] [Full Text] [Related]
17. Oroxylin A improves attention deficit hyperactivity disorder-like behaviors in the spontaneously hypertensive rat and inhibits reuptake of dopamine in vitro. Yoon SY, dela Peña I, Kim SM, Woo TS, Shin CY, Son KH, Park H, Lee YS, Ryu JH, Jin M, Kim KM, Cheong JH. Arch Pharm Res; 2013 Jan 15; 36(1):134-40. PubMed ID: 23371806 [Abstract] [Full Text] [Related]
19. Droxidopa alters dopamine neuron and prefrontal cortex activity and improves attention-deficit/hyperactivity disorder-like behaviors in rats. Dela Peña I, Shen G, Shi WX. Eur J Pharmacol; 2021 Feb 05; 892():173826. PubMed ID: 33347825 [Abstract] [Full Text] [Related]
20. Methylphenidate affects striatal dopamine differently in an animal model for attention-deficit/hyperactivity disorder--the spontaneously hypertensive rat. Russell VA, de Villiers AS, Sagvolden T, Lamm MC, Taljaard JJ. Brain Res Bull; 2000 Sep 15; 53(2):187-92. PubMed ID: 11044595 [Abstract] [Full Text] [Related] Page: [Next] [New Search]